Placebo News and Research

RSS

Aspirin shows no benefit in preventing breast cancer recurrence, study finds

Whether aspirin decreases the risk of invasive cancer events among survivors of breast cancer.

2 May 2024

Psilocybin found to be more effective than controls for treating depression symptoms

Psilocybin - the active ingredient in "magic" mushrooms - is a more effective treatment for symptoms of depression than controls, providing further support for its potential as an antidepressant, suggests a study published by The BMJ today.

1 May 2024

New monoclonal antibody vaccine slashes malaria risk in children

A recent study demonstrates that the monoclonal antibody-based vaccine L9LS is safe for children aged 6 to 10 and significantly reduces the risk of malaria infection and clinical symptoms by 70% and 77%, respectively.

30 Apr 2024

Psychedelic compound shows promise in stress relief for socially aggressive mice

A study in Neuropharmacology reveals that a single dose of the psychedelic compound (R)-DOI significantly improves stress-coping behaviors and reduces inflammatory markers in mice subjected to social aggression.

30 Apr 2024

Georgetown study raises concerns over aspirin's role in breast cancer treatment

A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University's Lombardi Comprehensive Cancer Center.

29 Apr 2024

Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows

One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country's six-month malaria season, according to the results of a mid-stage clinical trial.

26 Apr 2024

Japanese researchers test cardiac spheroids for heart regeneration in monkeys

Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function.

26 Apr 2024

Exploring the potential of ketogenic diets in managing epilepsy

The mechanisms of action, efficacy, and side effects of ketogenic diet (KD) variations in epileptic patients.

26 Apr 2024

Advancing medical treatment with causal machine learning

Machines can learn not only to make predictions, but also to handle causal relationships. An international research team shows how this could make therapies safer, more efficient, and more individualized.

25 Apr 2024

Monoclonal antibody Prasinezumab shows promise in slowing rapid Parkinson's progression

A recent study in Nature Medicine evaluated the efficacy of prasinezumab, a monoclonal antibody, in slowing the progression of motor symptoms in Parkinson’s disease patients with rapidly progressing forms, using phase II clinical trial data.

19 Apr 2024

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients

A trial of lixisenatide to assess its effects in early Parkinson’s disease.

18 Apr 2024

Exploring the benefits of blueberries: Studies link extract to reduced cognitive aging

Wild blueberry extracts (WBE) may improve cognitive performance.

18 Apr 2024

Phase 3 trial shows overall survival benefit from adjuvant therapy in kidney cancer patients

For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.

17 Apr 2024

Study finds microdosing LSD leads to longer sleep: Insights from a controlled trial

A phase I trial to assess the effect of micro-dosing of lysergic acid diethylamide (LSD) on the sleep.

17 Apr 2024

Managing diabetes with probiotics and synbiotics

Systematic review in Clinical Nutrition analyzed randomized trials to assess the impact of prebiotics and synbiotics on glycemic control in diabetes, revealing significant benefits in fasting glucose, serum insulin, and HbA1C levels.

16 Apr 2024

Study shows potential for universal flu vaccine with broad antibody response

Study discusses the potential of universal influenza vaccines, emphasizing the importance of antibody breadth and Fc receptor (FcR) effector functions in protecting against various influenza strains, including those with pandemic potential.

15 Apr 2024

Roasted green tea boosts mental task performance, study finds

Study examines how the consumption of green tea and roasted green tea affects human responses during mental tasks, demonstrating that roasted green tea can enhance performance and reduce fatigue.

15 Apr 2024

Esketamine after childbirth cuts risk of postnatal depression by three-quarters

Low-dose esketamine administered post-labor significantly reduced depressive symptoms in women with prenatal depression within 42 days, despite an increase in short-lived neuropsychiatric side effects.

14 Apr 2024

Cannabis compound d-limonene reduces anxiety-inducing effects of THC

A Johns Hopkins Medicine-led research team has added to evidence that a chemical found naturally in cannabis (also known as marijuana) can -; in the right amounts -; lessen the anxiety-inducing effects of tetrahydrocannabinol (THC), the primary psychoactive sister chemical found in cannabis.

12 Apr 2024

Low dose esketamine injection after childbirth reduces postpartum depression

A single low dose injection of esketamine given immediately after childbirth reduces major depressive episodes in individuals with depressive symptoms during pregnancy (prenatal depression), finds a clinical trial published by The BMJ today.

12 Apr 2024

Placebo News and Research

Aspirin shows no benefit in preventing breast cancer recurrence, study finds

Psilocybin found to be more effective than controls for treating depression symptoms

New monoclonal antibody vaccine slashes malaria risk in children

Psychedelic compound shows promise in stress relief for socially aggressive mice

Georgetown study raises concerns over aspirin's role in breast cancer treatment

Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows

Japanese researchers test cardiac spheroids for heart regeneration in monkeys

Exploring the potential of ketogenic diets in managing epilepsy

Advancing medical treatment with causal machine learning

Monoclonal antibody Prasinezumab shows promise in slowing rapid Parkinson's progression

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients

Exploring the benefits of blueberries: Studies link extract to reduced cognitive aging

Phase 3 trial shows overall survival benefit from adjuvant therapy in kidney cancer patients

Study finds microdosing LSD leads to longer sleep: Insights from a controlled trial

Managing diabetes with probiotics and synbiotics

Study shows potential for universal flu vaccine with broad antibody response

Roasted green tea boosts mental task performance, study finds

Esketamine after childbirth cuts risk of postnatal depression by three-quarters

Cannabis compound d-limonene reduces anxiety-inducing effects of THC

Low dose esketamine injection after childbirth reduces postpartum depression

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News